TPG’s likely stake sale is seen attracting global PE funds which have already struck several deals in India’s pharma and
healthcare sector Private equity investor TPG Capital is looking to exit its five-year-old investment in Hyderabad-based
Sai Life Sciences, a pharmaceutical contract development and manufacturing organisation (CDMO), according to three people aware of the development, a move that could fetch the PE firm as much as $500 million for its minority stake in the company.

Comments are closed.